Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. CVS Health
WARNING LETTER
•CVS Health•September 12, 2023

CVS Health – FDA Warning Letter, Sep 12, 2023

Record Details

The FDA issued a Warning Letter to CVS on September 11, 2023, following a July 2023 review of their website, www.cvs.com. The letter identifies "CVS Health Pink Eye Relief Drops" as an unapproved new drug, violating sections 505(a) and 301(d) of the FD&C Act (21 U.S.C. 355(a) and 331(d)). The product is deemed a "new drug" under section 201(p) (21 U.S.C. 321(p)) because it is not generally recognized as safe and effective (GRASE) for its intended uses, and no FDA-approved application is in effect.

The FDA expressed significant public health concerns due to the ophthalmic route of administration, which bypasses natural defenses. The product's labeling, including claims on the website, provides evidence of its intended use as a drug. Although labeled as homeopathic, the FDA states that homeopathic drugs are subject to the same statutory requirements, including FDA approval.

Furthermore, the product is considered adulterated under section 501(a)(2)(B) of the FD&C Act (21 U.S.C. 351(a)(2)(B)) because it was manufactured by a contract manufacturer, (b)(4), which

Company
CVS Health
Inspection date
September 12, 2023
Product type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • Jill P. Furman (Director)
View Company Profile

ID · 26537b71-aea1-4fb1-bda8-0636814c5761

Violation Codes10
21.U.S.C. 355(a)21 U.S.C. 331(d)21 U.S.C. 321(g)(1)21 U.S.C. 321(p)21 U.S.C. 331(c)FD&C Act 505(a)FD&C Act 301(d)FD&C Act 501(a)(2)(B)FD&C Act 301(a)FD&C Act 301(c)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore CVS Health
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.